Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Endovia Health Sciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Endovia Health Sciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bondurant Michael Breen | Chief Operating Officer | – | Jun 15, 2026 | 1 |
| Scott Martin P | Interim CFO | – | Jun 10, 2026 | 1 |
| Francis Knuettel II | Director | – | Jun 10, 2026 | 1 |
| Fore Thomas Butler | Director | – | Jun 10, 2026 | 2 |
| Caple Frederick William | Director | 1,875Indirect | Jun 10, 2026 | 3 |
| Cobb Brady James | Interim CEO | – | Jun 10, 2026 | 1 |
| Yorke Justin W | Director | – | Oct 15, 2025 | 1 |
| Nistico Robert | CEO and Chairman | 38,053 | Oct 15, 2025 | 2 |
| Devereux William T | Chief Financial Officer | – | Oct 15, 2025 | 2 |
| Meissner William R. | President and CMO | – | Oct 14, 2025 | 1 |
| Ivancsits Julius Paul | Chief Financial Officer | – | May 6, 2024 | 0 |
| Paglia John Kenneth | Director | – | Mar 7, 2024 | 0 |
| Dhalla Fatima | Interim CFO | – | Oct 16, 2023 | 0 |
| Wall Ronald Charles | Chief Financial Officer | – | Aug 3, 2023 | 0 |
| McDonough Peter J | Director | – | May 15, 2023 | 0 |
| Crawford Candace | Director | – | May 15, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2023 (view filing) | Jun 16 | Same day | Nistico RobertCEO and Chairman | PPurchase | +7.00K | $1.01 | +$7.07K | +0.5%1.39M after | |
| Apr 14, 2023 (view filing) | Apr 14 | Same day | Nistico RobertCEO and Chairman | PPurchase | +12.0K | $1.15 | +$13.8K | +0.9%1.38M after | |
| Apr 13, 2023 (view filing) | Apr 13 | Same day | Nistico RobertCEO and Chairman | PPurchase | +17.0K | $1.17 | +$19.9K | +1.3%1.37M after | 2 lots |
| Jun 16, 2022 (view filing) | Jun 15-16 | 1 day | Nistico RobertCEO and Chairman | PPurchase | +4.00K | $1.72 | +$6.88K | +0.3%1.33M after | 5 lots |
| Jun 7, 2022 (view filing) | Jun 3 | 4 days | Nistico RobertCEO and Chairman | PPurchase | +2.00K | $2.06 | +$4.11K | +0.2%1.32M after | 2 lots |
| May 31, 2022 (view filing) | May 26-27 | 5 days | Nistico RobertCEO and Chairman | PPurchase | +11.0K | $2.00 | +$22.0K | +0.8%1.32M after | 7 lots |